BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 25749265)

  • 21. How health reform legislation will affect Medicare beneficiaries.
    Guterman S; Davis K; Stremikis K
    Issue Brief (Commonw Fund); 2010 Mar; 81():1-10. PubMed ID: 20297561
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacist's role in home i.v. therapy.
    McAllister JC
    Am J Hosp Pharm; 1989 Jul; 46(7 Pt 2):S10-4. PubMed ID: 2505613
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HCFA clarifies 'incident-to' billing by pharmacists.
    Am J Health Syst Pharm; 2000 Sep; 57(17):1557-8. PubMed ID: 10984801
    [No Abstract]   [Full Text] [Related]  

  • 24. States, Congress confront abortion services under Medicaid, health care plan.
    Wash Memo Alan Guttmacher Inst; 1994 Jan; (1):3-4. PubMed ID: 12345518
    [TBL] [Abstract][Full Text] [Related]  

  • 25. International Academy of Compounding Pharmacists. Legislative/regulatory update. Preserving patient access--compounders on Capitol Hill 2013!
    Miller DG
    Int J Pharm Compd; 2013; 17(4):302-4. PubMed ID: 24261145
    [No Abstract]   [Full Text] [Related]  

  • 26. Identification of medication-related problems and health care provider acceptance of pharmacist recommendations in the DiabetesCARE program.
    DeName B; Divine H; Nicholas A; Steinke DT; Johnson CL
    J Am Pharm Assoc (2003); 2008; 48(6):731-6. PubMed ID: 19019801
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The outlook for pharmacist initiation and modification of drug therapy.
    Shefcheck SL; Thomas J
    J Am Pharm Assoc (Wash); 1996 Oct; NS36(10):597-604. PubMed ID: 8908936
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Initial perceptions of key stakeholders in Ontario regarding independent prescriptive authority for pharmacists.
    Pojskic N; MacKeigan L; Boon H; Austin Z
    Res Social Adm Pharm; 2014; 10(2):341-54. PubMed ID: 23816494
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Billing third party payers for pharmaceutical care services.
    Poirier S; Buffington DE; Memoli GA
    J Am Pharm Assoc (Wash); 1999; 39(1):50-64; quiz 101-2. PubMed ID: 9990188
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Disease prevention policy under Medicare: a historical and political analysis.
    Schauffler HH
    Am J Prev Med; 1993; 9(2):71-7. PubMed ID: 8471273
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Medicare Part D: successes and continuing challenges. Impact of Medicare Part D on Massachusetts health programs and beneficiaries.
    Thomas CP; Sussman J; ;
    Issue Brief (Mass Health Policy Forum); 2007 May; (32):1-32. PubMed ID: 17546802
    [TBL] [Abstract][Full Text] [Related]  

  • 32. SGR reform and nephrology: difficult problems, potential solutions.
    Velez R; Singer D; Blaser R
    Nephrol News Issues; 2012 Sep; 26(10):12, 14-5. PubMed ID: 23033621
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Veto -- or threat thereof -- prevails over majority as 102nd Congress adjourns.
    Wash Memo Alan Guttmacher Inst; 1992 Oct; (15):2-4. PubMed ID: 12317790
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Financial implications of pharmacist-led Medicare annual wellness visits.
    Park I; Sutherland SE; Ray L; Wilson CG
    J Am Pharm Assoc (2003); 2014; 54(4):435-40. PubMed ID: 25063264
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Medicare program; diagnosis codes on physician bills--HCFA. Final rule.
    Fed Regist; 1994 Mar; 59(43):10290-9. PubMed ID: 10133583
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Academic pharmacy and patient-centered health care: a model to prepare the next generation of pharmacists.
    Haines SL; DeHart RM; Flynn AA; Hess KM; Marciniak MW; Mount J; Phillips BB; Saseen JJ; Zatzkin SW
    J Am Pharm Assoc (2003); 2011; 51(2):194-202. PubMed ID: 21382810
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Legislation proposes adding pharmacist services to Medicare.
    Thompson CA
    Am J Health Syst Pharm; 2014 Apr; 71(8):606-7. PubMed ID: 24688029
    [No Abstract]   [Full Text] [Related]  

  • 38. Report of the 2015 APhA House of Delegates.
    J Am Pharm Assoc (2003); 2015; 55(4):364-75. PubMed ID: 26161480
    [No Abstract]   [Full Text] [Related]  

  • 39. Patient-centered health care using pharmacist-delivered medication therapy management in rural Mississippi.
    Ross LA; Bloodworth LS
    J Am Pharm Assoc (2003); 2012; 52(6):802-9. PubMed ID: 23229968
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Billing for pharmacists' cognitive services in physicians' offices: multiple methods of reimbursement.
    Scott MA; Hitch WJ; Wilson CG; Lugo AM
    J Am Pharm Assoc (2003); 2012; 52(2):175-80. PubMed ID: 22370380
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.